Company intelligence / Profile preview

Xi'an Qinshen Jiahe Pharmaceutical Research

Xian, Shaanxi Sheng, China

Ownership: Private
Development stage: Other

Overview

Xi'an Qinshen Jiahe Pharmaceutical Research is a private pharmaceutical company based in Shaanxi, China, founded in 2018. The company focuses on the development of chemical drugs for nervous system and cardiovascular diseases. Its lead program, YZD-27, is being evaluated for safety and pharmacokinetics in healthy subjects as an injectable treatment for acute ischemic stroke and has entered early clinical trials as of August 2024[6].

Therapeutic areas: NeurologyCardiovascular
Modalities: Small molecule
Industry: Biotech

Drug pipeline

1 asset

YZD-27

Partnerships

None publicly disclosed[6]

Beyond the preview

Go deeper on Xi'an Qinshen Jiahe Pharmaceutical Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xi'an Qinshen Jiahe Pharmaceutical Research.